Cheong, Jae-Ho http://orcid.org/0000-0002-1703-1781
Wang, Sam C. http://orcid.org/0000-0003-3626-5273
Park, Sunho
Porembka, Matthew R.
Christie, Alana L.
Kim, Hyunki http://orcid.org/0000-0003-2292-5584
Kim, Hyo Song
Zhu, Hong http://orcid.org/0000-0001-8562-3351
Hyung, Woo Jin
Noh, Sung Hoon http://orcid.org/0000-0003-4386-6886
Hu, Bo http://orcid.org/0000-0003-0606-7639
Hong, Changjin
Karalis, John D.
Kim, In-Ho
Lee, Sung Hak
Hwang, Tae Hyun http://orcid.org/0000-0002-6668-7269
Funding for this research was provided by:
Korea Health Industry Development Institute (HI13C2162, HI13C2162)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08 CA222611, K08 CA222611)
Burroughs Wellcome Fund (1018897, 1018897)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 12 May 2021
Accepted: 21 January 2022
First Online: 9 February 2022
Competing interests
: J.C., S.C.W., S.P., S.H.L., and T.H.H. are co-inventors of a patent for the 32 gene signature which is currently under consideration (PCT/KR2021/018966). All other authors declare no competing interests.